Results 221 to 230 of about 1,415,739 (335)

IL-17A; IL-23 [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

IL-23 specifics in spondyloarthritis [PDF]

Nature Reviews Rheumatology, 2012
openaire   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Neuropsychiatric Outcomes of IL-17 and IL-23 Inhibitors in Dermatology: Risks, Benefits, and Clinical Implications. [PDF]

Int J Dermatol
Tan IJ, Mitelman A, Jafferany M.
europepmc   +1 more source

IL-22 and IL-23 regulate the anticryptococcal response during Cryptococcus deuterogattii infection

Israel Diniz-Lima, Ariel Gomes, Mayck Medeiros, Joyce Cristina Guimarães-de-Oliveira, Idália Maria Ferreira-dos-Santos, Elias Barbosa da Silva-Júnior, Alexandre Morrot, Danielle Oliveira Nascimento, Leonardo Freire‐de‐Lima, Lycia de Brito‐Gitirana, Fernanda Ferreira Cruz, Débora Decotè-Ricardo, Herbert Leonel de Matos Guedes, Célio Geraldo Freire-de-Lima   +13 more
openalex   +1 more source

IL-23 promotes arthritic and inflammatory pain [PDF]

Nature Reviews Rheumatology, 2020
openaire   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Aberrant expression of IL-23/IL-23R in patients with breast cancer and its clinical significance

, 2018
Shuhai Sheng, Jinji Zhang, Jianzhong Ai, Xueli Hao, Ruishen Luan   +4 more
openalex   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia. [PDF]

Int J Mol Sci
Cardillo M, Ferrero F, Bertola N, Nano E, Massara R, Capra MC, Reverberi D, Colombo M, Cossu V, Ghiotto F, Ibatici A, Angelucci E, Neri A, Gentile M, Morabito F, Mazzarello AN, Ferrarini M, Fais F, Cutrona G.   +18 more
europepmc   +1 more source